Exploring the Impact Healthcare Mergers Can Have on Your Lab
We’ve recently seen a number of high-profile healthcare mergers, and as these changes accelerate, we’ve been working to keep our clients informed of how they could be impacted by deals involving their health systems or organizations. While some...
Examining Common Denial Reasons for Drug Screenings
By: Dyana Williams, Client Engagement Manager, Lighthouse RCM Solutions Presumptive drug testing screens for drug presence, while definitive testing identifies specific drugs and concentrations. Both aid in patient care and treatment decisions. In the world of...
CMS to Withdraw NCCI Edit Impacting Drug Testing
CMS is withdrawing NCCI PTP edits between Column One codes 80305, 80306, and 80307 for presumptive test(s), and Column Two codes G0480 – G0483, and G0659 for definitive test(s), according to an announcement posted on the agency’s website and communications from...
Solutions for Sustaining Clinical Pathology Revenue Amidst Challenges
By: Dyana Williams, Client Engagement Manager, LLS RCM Solutions For hospital-based pathology groups, mastering the complex revenue cycle management processes surrounding the capture and billing of Professional Component of Clinical Laboratory (PCCP) services is...